Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AVTR — Avantor, Inc.

CIK 1423053 MIAMI, FL
Back to AVTR Full portfolio

Position in AVTR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,464,966
-$9,790,769 QoQ
Shares Held
569,511
-54.2% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AVTR Over Time

Shares Held

Position Value (USD)

Derivatives in AVTR

reported options exposure · as of Mar 31, 2026
CallValue
$235,984
CallShares
30,100
PutValue
$497,840
PutShares
63,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,983,617,750 across 42 Medical Instruments & Supplies names. AVTR ranks #26 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ISRG
Intuitive Surgical Inc
 1,356,011 $625,107,510
2 TFX
Teleflex Inc
 1,171,096 $140,074,791
3 BDX
Becton Dickinson & Co
 829,501 $130,422,441
4 RGEN
Repligen Corp
 1,099,181 $129,505,505
5 ALGN
Align Technology Inc
 730,025 $125,148,185
6 NVST
Envista Holdings Corp
 4,584,572 $116,310,591
7 HOLX
HOLOGIC INC
 1,090,660 $82,442,989
8 WST
West Pharmaceutical Services Inc
 323,587 $81,103,845

All Filings in AVTR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $497,840 63,500
2026-03-31 $235,984 30,100
2026-03-31 $4,464,966 569,511
2025-12-31 $14,255,735 1,243,956
2025-12-31 $4,205,820 367,000
2025-12-31 $389,640 34,000
2025-09-30 $808,704 64,800
2025-09-30 $4,382,976 351,200
2025-09-30 $99,502,216 7,972,934
2025-06-30 $3,204,826 238,100
2025-06-30 $6,289,858 467,300
2025-06-30 $37,552,376 2,789,924
2025-03-31 $3,073,416 189,600
2025-03-31 $5,696,210 351,401
2025-03-31 $7,741,896 477,600
2024-12-31 $7,565,562 359,068
2024-12-31 $4,803,960 228,000
2024-12-31 $6,761,363 320,900
2024-09-30 $8,092,136 312,800
2024-09-30 $4,855,799 187,700
2024-09-30 $41,835,851 1,617,157
2024-06-30 $41,949,415 1,978,746
2024-06-30 $3,824,480 180,400
2024-06-30 $13,025,280 614,400
2024-03-31 $88,768,812 3,471,600
2024-03-31 $2,477,733 96,900
2024-03-31 $8,339,092 326,128
2023-12-31 $8,531,571 373,700
2023-12-31 $68,533,993 3,001,927
2023-12-31 $4,776,036 209,200
2023-09-30 $2,472,684 117,300
2023-09-30 $10,244,880 486,000
2023-09-30 $4,944,524 234,560
2023-06-30 $6,065,462 295,300
2023-06-30 $1,760,278 85,700
2023-03-31 $20,911,772 989,204
2023-03-31 $7,202,398 340,700
2023-03-31 $621,516 29,400
2022-12-31 $388,056 18,400
2022-12-31 $1,590,186 75,400
2022-12-31 $37,117,555 1,759,960
2022-09-30 $1,102,264 56,238
2022-09-30 $12,589,080 642,300
2022-09-30 $662,480 33,800
2022-06-30 $3,486,310 112,100
2022-06-30 $136,008,447 4,373,262
2022-06-30 $531,810 17,100
2022-03-31 $5,123,730 151,500
2022-03-31 $1,379,856 40,800
2022-03-31 $16,671,704 492,954

Report a Problem

Category
Description
Email (optional, for follow-up)